Dynatronics Corporation

DYNTQ Healthcare Medical Devices

Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$1.2M
P/E
0.0×
Fwd P/E
−1.5×
Dividend yield
—
F-score
3/9
Altman Z
−2.33
Beneish M
−6.52
Dividend safety
n/a
Older periods Dec '24 Mar '25 Jun '25 Sep '25
Piotroski F-Score

+8 more TTM periods

5 6 3 3
ROE
(50.72%) (64.70%) (1,588.36%) (2,563.17%)
ROA
(11.60%) (13.78%) (56.08%) (57.18%)
ROIC
(8.10%) (10.20%) (25.59%) (24.36%)
Return on Tangible Assets
(88.58%) (125.60%) (519.88%) (573.14%)
Average Days of Receivables
36.95 38.72 39.80 37.82
Free Cash Flow per Share
(0.01) 0.05 0.03 0.01
Free Cash Flow
(0.07) 0.42 0.27 0.08
Other line items

Show all line items

Columns are period end dates